5,000,000 Shares CORGENTECH INC. Common Stock UNDERWRITING AGREEMENTCorgentech Inc • February 6th, 2004 • Pharmaceutical preparations • New York
RESTATED AND AMENDED EXCLUSIVE LICENSE AGREEMENTAnd Amended Exclusive License Agreement • February 6th, 2004 • Corgentech Inc • Pharmaceutical preparations • California
Effective as of January 1, 1999 ("Effective Date"), THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California ("STANFORD") and Corgentech Inc., a Delaware corporation have a primary place of business at Suite 460, 601 Gateway Boulevard, South San Francisco, California 94080, ("LICENSEE"), agree as follows:
RESTATED AND AMENDED LICENSE AGREEMENT (BWH #A5288)And Amended License Agreement • February 6th, 2004 • Corgentech Inc • Pharmaceutical preparations • Massachusetts
Effective as of January 1, 1999 ("Effective Date"), The Brigham and Women's Hospital, Inc., a Massachusetts non-profit organization having a business address at 75 Francis Street, Boston, MA 02115 ("BWH") and Corgentech Inc., a Delaware corporation having a primary place of business at Suite 460, 601 Gateway Boulevard, South San Francisco, California 94080, ("LICENSEE"), agree as follows:
COLLABORATION AGREEMENT BY AND BETWEEN BRISTOL-MYERS SQUIBB COMPANY AND CORGENTECH INC.Collaboration Agreement • February 6th, 2004 • Corgentech Inc • Pharmaceutical preparations • New York
THIS COLLABORATION AGREEMENT (the "Agreement") is made by and between Corgentech Inc., a Delaware corporation having its principal place of business at 650 Gateway Boulevard, South San Francisco, CA 94080 ("Corgentech") and Bristol-Myers Squibb Company, a Delaware corporation headquartered at 345 Park Avenue, New York, New York 10154 ("BMS"), effective as of the date signed by the last Party to sign below (the "Effective Date"). Corgentech and BMS are sometimes referred to herein individually as a "Party" and collectively as the "Parties."
